Home The Active Ingredient Matrix Ubiquinone (Coenzyme Q10)

Formulation Intelligence

Ubiquinone (Coenzyme Q10)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Ubiquinone (Coenzyme Q10).

Ubiquinone functions as a critical lipophilic electron carrier in the mitochondrial respiratory chain, facilitating ATP synthesis through oxidative phosphorylation while mitigating oxidative stress via the neutralization of lipid peroxyl radicals.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

5281915

Molecular Weight

863.3 g/mol

XLogP3 (Lipophilicity)

19.4

IUPAC Name

2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

  • L-Carnitine for synergistic mitochondrial energy production via enhanced fatty acid transport
  • Vitamin E for regenerative antioxidant cycling and stabilization of the lipid bilayer

Biological Formulation Enhancers

  • Piperine for the inhibition of metabolic glucuronidation and enhancement of intestinal absorption
  • Lecithin for the formation of lipid-based micelles to improve the solubility of the hydrophobic molecule

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Ubiquinone (Coenzyme Q10) across standard consumer modalities.

💊 Standard Capsules

The crystalline nature and high lipophilicity of ubiquinone necessitate lipid-based softgel formulations to overcome the poor dissolution rates and low bioavailability inherent in standard dry powder capsules.

🍬 Gummy & Pectin Formats

The relatively low melting point of ubiquinone poses a risk of phase separation and uneven distribution within the gummy matrix during the high-heat depositing process.

🔬 Thin-Film Oral Strips

The high therapeutic dosage requirements for ubiquinone significantly exceed the typical 30mg payload limit of thin-film oral strips, necessitating multiple applications for a single clinical dose.

For Brand Founders

Formulate with Ubiquinone (Coenzyme Q10)

Ready to launch a product featuring Ubiquinone (Coenzyme Q10)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Ubiquinone (Coenzyme Q10) Bioavailability

Need absolute proof that your Ubiquinone (Coenzyme Q10) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Ubiquinone (Coenzyme Q10) Degradation Testing

Is your Ubiquinone (Coenzyme Q10) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation